Clinical Trials Directory

Trials / Completed

CompletedNCT07404930

L. Reuteri SGL 01 in Nursing Mothers: Effects on Milk Microbiota and Neonatal Gut Colonization

Supplementation With L. Reuteri SGL 01 in Nursing Mothers: Evaluation of the Microbiota in Breast Milk and Intestinal Colonization in Newborns

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The Reuteri17 study is a spontaneous, prospective, randomized intervention study designed to evaluate the effects of maternal supplementation with the probiotic Lactobacillus reuteri SGL 01 on the composition of the breast milk microbiota and subsequent intestinal colonization of the newborn. The protocol involves the enrollment of 20 primiparous mothers of full-term, exclusively breastfed infants. Participants are divided into two groups: the first receives a daily supplement of 5 drops of Reuplus® (equivalent to 1 billion live cultures), while the second serves as a non-supplemented control group. The effectiveness of the intervention is monitored through two sampling moments: at baseline (T0) and after 30 days of treatment (T1). Specifically, 20 ml samples of breast milk and fecal samples from the newborns are collected. Bacterial DNA is extracted from these biological matrices and analyzed using real-time PCR at the University of Bologna, with the aim of quantifying changes in the microbiota and the transfer of the probiotic strain. To complete the investigation, mothers are given a nutritional questionnaire to correlate the results with dietary habits. The study aims to confirm that maternal oral supplementation can be an effective strategy for modulating the bacterial heritage of newborns during the first months of life.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTprobiotic Lactobacillus reuteri SGL 015 drops of supplement based on lactic acid bacteria consisting exclusively of Lactobacillus Reuteri SGL 01

Timeline

Start date
2017-10-16
Primary completion
2021-01-31
Completion
2025-12-31
First posted
2026-02-12
Last updated
2026-02-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07404930. Inclusion in this directory is not an endorsement.